Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Xenetic Biosciences Inc.
DescriptionLong-acting erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard IndicationAnemia
Indication DetailsTreat anemia in chronic kidney disease (CKD) patients; Treat anemia in chronic kidney disease (CKD) patients not requiring dialysis; Treat anemia in chronic renal failure patients on dialysis; Treat anemia in patients receiving renal dialysis
Regulatory Designation
PartnerSerum Institute of India Ltd.;
SynBio LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today